sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
28-Aug-2016 18:34
US Eastern Time




Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books



Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation


Submit a Calendar Item


Links & Resources


RSS Feeds

Accessibility Option On


Portal Home


Background Articles

Research Papers


Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 876-900 out of 1298.

<< < 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 > >>

Public Release: 28-Apr-2015
PLOS Medicine
As circumcision wounds heal, HIV-positive men may spread virus to female partners
In a campaign to slow the spread of HIV in sub-Saharan Africa, the World Health Organization recommends male circumcision, which reduces HIV acquisition by 50-60 percent. A new study of HIV-infected men in Uganda has identified a temporary, but potentially troublesome unintended consequence: a possible increased risk of infecting female sexual partners over a few weeks while circumcision wounds heal. Men taking anti-HIV drugs were 90% less likely to shed virus during healing.
Bill and Melinda Gates Foundation, Doris Duke Charitable Foundation, NIH/National Institute of Allergy and Infectious Diseases, NIH/Fogarty International Center

Contact: Heather Dewar
Johns Hopkins Medicine

Public Release: 27-Apr-2015
Antimicrobial Agents and Chemotherapy
Stopping HIV in its tracks
Findings published this week in Antimicrobial Agents and Chemotherapy report that a novel, subdermal implant delivering potent antiretroviral drugs shows extreme promise in stopping the spread of HIV. Scientists from the Oak Crest Institute of Science, in Pasadena, Calif., report that they have developed a matchstick size implant, similar to a contraceptive implant, that successfully delivers a controlled, sustained release of ARV drugs up to 40 days in dogs with no adverse side effects.

Contact: Dr. Marc Baum
Oak Crest Institute of Science

Public Release: 27-Apr-2015
Proceedings of the National Academy of Sciences
International research team discovers new mechanism behind malaria progression
A team of researchers from four universities, including Carnegie Mellon, has pinpointed one of the mechanisms responsible for the progression of malaria, providing a new target for possible treatments. Using computer modeling, the group found that nanoscale knobs, which form at the membrane of infected red blood cells, cause the cell stiffening that is in part responsible for the reduced blood flow that can turn malaria deadly.
National Science Foundation

Contact: Jocelyn Duffy
Carnegie Mellon University

Public Release: 27-Apr-2015
World's largest open source health information technology project tackles Ebola
An accurate, up to the minute, accessible medical record system is fundamental to effective treatment and tracking of the Ebola virus. But how to create this type of system in the rudimentary, overwhelmed Ebola care centers of West Africa where paper records or computers -- even if they were available -- couldn't be carried in and out of treatment areas? OpenMRS community put out call to action to respond to the outbreak, and volunteers from around the world responded.

Contact: Cindy Fox Aisen
Indiana University

Public Release: 27-Apr-2015
20th Asia Pacific Society of Cardiology Congress
Abu Dhabi meeting aims to stem rising risk of cardiovascular disease
The American College of Cardiology will host sessions on the prevention of cardiovascular disease and treatments for heart failure at the 20th Asia Pacific Society of Cardiology Congress in Abu Dhabi in the United Arab Emirates. Given the growing burden of diabetes and cardiovascular disease in the Middle East, the setting of the United Arab Emirates provides context for the importance of bringing together global leaders in cardiovascular disease prevention and treatment.

Contact: Katie Glenn
American College of Cardiology

Public Release: 24-Apr-2015
York's anti-malarial plant given Chinese approval
A new hybrid plant used in anti-malarial drug production, developed by scientists at the University of York's Centre for Novel Agricultural Products, is now registered as a new variety in China.
Bill and Melinda Gates Foundation

Contact: Saskia Angenent
University of York

Public Release: 23-Apr-2015
PLOS Computational Biology
Finding new life for first-line antibiotics
Researchers have identified a single, simple measure -- recovery time -- to guide antibiotic dosing that could bring an entire arsenal of first-line antibiotics back into the fight against drug-resistant pathogens.
National Science Foundation, National Institutes of Health, DuPont Young Professorship Award, David and Lucile Packard Fellowship, National Science Foundation Graduate Research Fellowship, Howard G. Clark Fellowship

Contact: Ken Kingery
Duke University

Public Release: 22-Apr-2015
Lancet Infectious Diseases
Researchers discover never-before-seen tick-borne disease
Just in time for spring and the explosion of ticks in forests, lawns and trails, a new study by researchers from China and the University of Maryland School of Medicine has uncovered a never-before-seen illness transmitted by ticks. The disease could be a 'substantial health threat' to humans and animals in areas where the carrier tick is common.

Contact: David Kohn
University of Maryland School of Medicine

Public Release: 22-Apr-2015
Journal of Virus Eradication
Global hepatitis B epidemic can be treated for $36 (£24) per person per year
Scientists at the University of Liverpool have demonstrated that a drug for treating hepatitis B virus could be mass-produced for only £24 ($36) per person per year, versus the current UK NHS price of £4,600, and the US price of over $15,000.

Contact: Sarah Stamper
University of Liverpool

Public Release: 22-Apr-2015
Ebola survivors donate plasma to tackle outbreak
The first donations of plasma, from survivors of the Ebola epidemic in Sierra Leone, have been received by an international research team working to help tackle current and future disease outbreaks in West Africa.
Wellcome Trust

Contact: Sarah Stamper
University of Liverpool

Public Release: 22-Apr-2015
PLOS Biology
Boosting the malaria battle-line
In a huge boost to the global fight against malaria, researchers have discovered how the malaria parasite protects itself by building resistance against the last-line in antimalarial medications, and how a new medical treatment can overcome the parasite's defenses.

Contact: Anne Rahilly
University of Melbourne

Public Release: 22-Apr-2015
Twins experiment reveals genetic link with mosquito bites
The likelihood of being bitten by mosquitoes could be down to our genes, according to a study carried out on twins.
Sir Halley Stewart Trust

Contact: Katie Steels
London School of Hygiene & Tropical Medicine

Public Release: 22-Apr-2015
UTMB researchers develop Ebola treatment effective 3 days after infection
Researchers from The University of Texas Medical Branch at Galveston and Tekmira Pharmaceuticals Corp., have successfully developed a post-exposure treatment that is effective against a specific strain of the Ebola virus that killed thousands of people in West Africa.
National Institutes of Health

Contact: Donna Ramirez
University of Texas Medical Branch at Galveston

Public Release: 21-Apr-2015
Book details misconceptions about smallpox's role in Native depopulation
As part of his new book, 'Cherokee Medicine, Colonial Germs: An Indigenous Nation's Fight against Smallpox, 1518-1824,' a University of Kansas history professor disputes the idea that infectious diseases themselves gave Europeans an advantage over Native-Americans because indigenous peoples did not have the right medicine or knowledge base to fight these new diseases, such as smallpox.

Contact: George Diepenbrock
University of Kansas

Public Release: 21-Apr-2015
Immune cells support good gut bacteria in fight against harmful bacteria
The immune cell protein ID2 is critical for the maintenance of healthy gut microbiota, helping good bacteria fight off harmful bacteria. This study, published in Immunity, shows how the immune system shapes the gut microbiota to limit infections.
National Institutes of Health

Contact: Ashley Heher
University of Chicago Medical Center

Public Release: 21-Apr-2015
Fourth Global Forum on TB Vaccines
New research points to elderly as growing contributor to tuberculosis in China
A major contributor to the number of tuberculosis infections and cases in China will likely be the elderly over the next decades, requiring a refocus in efforts to control a disease affecting millions in China, according to preliminary new research presented today at the Fourth Global Forum on TB Vaccines in Shanghai. Researchers from the LSHTM found that developing a 'post-infection' vaccine could reduce overall TB rates in China by almost a third by 2050.

Contact: Ellen Wilcox

Public Release: 20-Apr-2015
American Journal of Tropical Medicine and Hygiene
Notre Dame researchers detecting low quality antimalarial drugs with a lab-on-paper
Access to high-quality medicine is a basic human right, but over four billion people live in countries where many medications are substandard or fake. Marya Lieberman of the Department of Chemistry and Biochemistry at the University of Notre Dame and Abigail Weaver a postdoctoral associate in the University's Department of Civil Engineering and Environmental and Earth Sciences took up the challenge of how people in developing countries could detect low quality antimalarial drugs without expensive equipment and without handling dangerous chemicals.

Contact: Marya Lieberman
University of Notre Dame

Public Release: 20-Apr-2015
American Journal of Tropical Medicine and Hygiene
Global pandemic of fake medicines poses urgent risk, scientists say
Poor quality medicines are an urgent threat that could undermine decades of successful efforts to combat HIV/AIDS, malaria and TB, according to the editors of a journal supplement published today. Scientists report up to 41 percent of specimens failed to meet quality standards in global studies of about 17,000 drug samples. Seventeen articles are included in the supplement 'The Global Pandemic of Falsified Medicines,' published by The American Journal of Tropical Medicine and Hygiene.
NIH/Fogarty International Center, Bill & Melinda Gates Foundation, New Venture Fund

Contact: Ann Puderbaugh
NIH/Fogarty International Center

Public Release: 20-Apr-2015
American Journal of Tropical Medicine and Hygiene
Fake malaria drugs not as common as previously reported
A rigorous analysis of antimalarial drug quality conducted in Cambodia and Tanzania found no evidence of fake medicines, according to new research from the London School of Hygiene & Tropical Medicine.
Bill and Melinda Gates Foundation

Contact: Katie Steels
London School of Hygiene & Tropical Medicine

Public Release: 20-Apr-2015
Proceedings of the National Academy of Sciences
Cancer drug shows promise as cure for hepatitis B
Australian scientists have found a potential cure for hepatitis B virus infections, with a promising new treatment proving 100 percent successful in eliminating the infection in preclinical models. Australian patients are now the first in the world to have access to the potential treatment -- a combination of an antiviral drug and an anti-cancer drug -- which is in phase 1/2a clinical trials in Melbourne, Perth and Adelaide.
National Health and Medical Research Council, Australian Research Council, Victorian Government

Contact: Alan Gill
Walter and Eliza Hall Institute

Public Release: 19-Apr-2015
American Association for Cancer Research Annual Meeting 2015
Broccoli sprout extract promising for head and neck cancer prevention
Broccoli sprout extract protects against oral cancer in mice and proved tolerable in a small group of healthy human volunteers, the University of Pittsburgh Cancer Institute, partner with UPMC CancerCenter, announced today at the American Association for Cancer Research (AACR) Annual Meeting in Philadelphia.
NIH/National Cancer Institute

Contact: Allison Hydzik
University of Pittsburgh Schools of the Health Sciences

Public Release: 17-Apr-2015
Antimicrobial Agents and Chemotherapy
New genetic mutation could signal start of malaria drug resistance in Africa
Early indicators of the malaria parasite in Africa developing resistance to the most effective drug available have been confirmed, according to new research from the London School of Hygiene & Tropical Medicine.

Contact: Katie Steels
London School of Hygiene & Tropical Medicine

Public Release: 16-Apr-2015
Subsidies key in improving sanitation, new study finds
For years, governments and major development institutions have vigorously debated how to address poor sanitation in developing countries, which causes 280,000 deaths per year worldwide. A new study released in Science today found that in Bangladesh, a community-motivation model that has been used in over 60 countries to increase use of hygienic latrines had no effect, but that latrine coverage expands substantially when that model is combined with subsidies for hygienic latrines targeted to the poor.

Contact: Heidi McAnnally-Linz
Innovations for Poverty Action

Public Release: 16-Apr-2015
PLOS Neglected Tropical Diseases
160 people die of rabies every day, says major new study
A global study on canine rabies, published April 16, 2015, has found that 160 people die every single day from the disease. The report is the first study to consider the impact in terms of deaths and the economic costs of rabies across all countries. Even though the disease is preventable, 59,000 people die every year of rabies transmitted by dogs, and the disease costs global economies $8.6 billion US.
UBS Optimus Foundation, Wellcome Trust

Contact: Kevin Doran
Global Alliance for Rabies Control

Public Release: 15-Apr-2015
Canada, India fund 5 innovations to improve health in India, with focus on mothers and children
Canada and India today announced investments of CDN $2.5 million in five innovations in India aimed primarily at improving maternal, newborn and child health -- Canada's flagship development priority. Canadian government-funded Grand Challenges Canada and the Grand Challenges India initiative of the Government of India, made the joint announcement during the official visit to Canada of India's Prime Minister Narendra Modi.
Grand Challenges Canada, Grand Challenges India

Contact: Lode Roels
Grand Challenges Canada

Showing releases 876-900 out of 1298.

<< < 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 > >>